<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35732153</PMID><DateCompleted><Year>2022</Year><Month>06</Month><Day>24</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2666-3791</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>6</Issue><PubDate><Year>2022</Year><Month>Jun</Month><Day>21</Day></PubDate></JournalIssue><Title>Cell reports. Medicine</Title><ISOAbbreviation>Cell Rep Med</ISOAbbreviation></Journal><ArticleTitle>The IL-1&#x3b2;, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19.</ArticleTitle><Pagination><StartPage>100663</StartPage><MedlinePgn>100663</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100663</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.xcrm.2022.100663</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2666-3791(22)00195-1</ELocationID><Abstract><AbstractText>Post-acute sequelae of COVID-19 (PASC) is emerging as global problem with unknown molecular drivers. Using a digital epidemiology approach, we recruited 8,077 individuals to the cohort study for digital health research in Germany (DigiHero) to respond to a basic questionnaire followed by a PASC-focused survey and blood sampling. We report the first 318 participants, the majority thereof after mild infections. Of those, 67.8% report PASC, predominantly consisting of fatigue, dyspnea, and concentration deficit, which persists in 60% over the mean 8-month follow-up period and resolves independently of post-infection vaccination. PASC is not associated with autoantibodies, but with elevated IL-1&#x3b2;, IL-6, and TNF plasma levels, which we confirm in a validation cohort with 333 additional participants and a longer time from infection of 10&#xa0;months. Blood profiling and single-cell data from early infection suggest the induction of these cytokines in COVID-19 lung pro-inflammatory macrophages creating a self-sustaining feedback loop.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 The Author(s). Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schulthei&#xdf;</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine IV, Oncology/Hematology, Martin-Luther-University Halle-Wittenberg, Ernst-Grube-Str. 40, 06120 Halle (Saale), Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Willscher</LastName><ForeName>Edith</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine IV, Oncology/Hematology, Martin-Luther-University Halle-Wittenberg, Ernst-Grube-Str. 40, 06120 Halle (Saale), Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paschold</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine IV, Oncology/Hematology, Martin-Luther-University Halle-Wittenberg, Ernst-Grube-Str. 40, 06120 Halle (Saale), Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gottschick</LastName><ForeName>Cornelia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute for Medical Epidemiology, Biometrics and Informatics (IMEBI), Interdisciplinary Center for Health Sciences, Medical School of the Martin-Luther University Halle-Wittenberg, Magdeburger Strasse 8, 06097 Halle (Saale), Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klee</LastName><ForeName>Bianca</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Institute for Medical Epidemiology, Biometrics and Informatics (IMEBI), Interdisciplinary Center for Health Sciences, Medical School of the Martin-Luther University Halle-Wittenberg, Magdeburger Strasse 8, 06097 Halle (Saale), Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henkes</LastName><ForeName>Svenja-Sibylla</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine IV, Oncology/Hematology, Martin-Luther-University Halle-Wittenberg, Ernst-Grube-Str. 40, 06120 Halle (Saale), Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bosurgi</LastName><ForeName>Lidia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20251 Hamburg, Germany; Protozoa Immunology, Bernhard Nocht Institute for Tropical Medicine, Bernhard Nocht Strasse 74, 20359 Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dutzmann</LastName><ForeName>Jochen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Mid-German Heart Center, Department of Cardiology and Intensive Care Medicine, University Hospital, Martin-Luther-University Halle-Wittenberg, Ernst-Grube-Str. 40, 06120 Halle (Saale), Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sedding</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Mid-German Heart Center, Department of Cardiology and Intensive Care Medicine, University Hospital, Martin-Luther-University Halle-Wittenberg, Ernst-Grube-Str. 40, 06120 Halle (Saale), Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frese</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute of General Practice and Family Medicine, Martin-Luther-University Halle-Wittenberg, Magdeburger Str. 8, 06112 Halle (Saale), Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Girndt</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Martin-Luther-University Halle-Wittenberg, Ernst-Grube-Str. 40, 06120 Halle (Saale), Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>H&#xf6;ll</LastName><ForeName>Jessica I</ForeName><Initials>JI</Initials><AffiliationInfo><Affiliation>Pediatric Hematology and Oncology, Martin-Luther-University Halle-Wittenberg, Ernst-Grube-Str. 40, 06120 Halle (Saale), Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gekle</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Julius Bernstein-Institute of Physiology, Faculty of Medicine, Martin-Luther-University Halle-Wittenberg, Magdeburger Str. 6, 06110 Halle (Saale), Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mikolajczyk</LastName><ForeName>Rafael</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute for Medical Epidemiology, Biometrics and Informatics (IMEBI), Interdisciplinary Center for Health Sciences, Medical School of the Martin-Luther University Halle-Wittenberg, Magdeburger Strasse 8, 06097 Halle (Saale), Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Binder</LastName><ForeName>Mascha</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine IV, Oncology/Hematology, Martin-Luther-University Halle-Wittenberg, Ernst-Grube-Str. 40, 06120 Halle (Saale), Germany. Electronic address: mascha.binder@uk-halle.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cell Rep Med</MedlineTA><NlmUniqueID>101766894</NlmUniqueID><ISSNLinking>2666-3791</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C508585">IL1B protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C508600">IL6 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053583">Interleukin-1beta</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014409">Tumor Necrosis Factor-alpha</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="Y">Cytokines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007159" MajorTopicYN="N">Immunologic Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053583" MajorTopicYN="N">Interleukin-1beta</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015850" MajorTopicYN="N">Interleukin-6</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014409" MajorTopicYN="N">Tumor Necrosis Factor-alpha</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">IL-1&#x3b2;</Keyword><Keyword MajorTopicYN="N">IL-6</Keyword><Keyword MajorTopicYN="N">PASC</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">TNF</Keyword><Keyword MajorTopicYN="N">cytokine</Keyword><Keyword MajorTopicYN="N">long covid</Keyword><Keyword MajorTopicYN="N">macrophage</Keyword><Keyword MajorTopicYN="N">post-acute sequelae of COVID-19</Keyword></KeywordList><CoiStatement>Declaration of interests The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>3</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>22</Day><Hour>18</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>6</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35732153</ArticleId><ArticleId IdType="pmc">PMC9214726</ArticleId><ArticleId IdType="doi">10.1016/j.xcrm.2022.100663</ArticleId><ArticleId IdType="pii">S2666-3791(22)00195-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Salian V.S., Wright J.A., Vedell P.T., Nair S., Li C., Kandimalla M., Tang X., Carmona Porquera E.M., Kalari K.R., Kandimalla K.K. COVID-19 transmission, current treatment, and future therapeutic strategies. Mol. Pharm. 2021;18:754&#x2013;771. doi: 10.1021/acs.molpharmaceut.0c00608.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.molpharmaceut.0c00608</ArticleId><ArticleId IdType="pubmed">33464914</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A., Singh R., Kaur J., Pandey S., Sharma V., Thakur L., Sati S., Mani S., Asthana S., Sharma T.K., et al. Wuhan to world: the COVID-19 pandemic. Front. Cell. Infect. Microbiol. 2021;11:596201. doi: 10.3389/fcimb.2021.596201.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.596201</ArticleId><ArticleId IdType="pmc">PMC8042280</ArticleId><ArticleId IdType="pubmed">33859951</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos-Casals M., Brito-Zer&#xf3;n P., Mariette X. Systemic and organ-specific immune-related manifestations of COVID-19. Nat. Rev. Rheumatol. 2021;17:315&#x2013;332. doi: 10.1038/s41584-021-00608-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-021-00608-z</ArticleId><ArticleId IdType="pmc">PMC8072739</ArticleId><ArticleId IdType="pubmed">33903743</ArticleId></ArticleIdList></Reference><Reference><Citation>Osuchowski M.F., Winkler M.S., Skirecki T., Cajander S., Shankar-Hari M., Lachmann G., Monneret G., Venet F., Bauer M., Brunkhorst F.M., et al. The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity. Lancet Respir. Med. 2021;9:622&#x2013;642. doi: 10.1016/S2213-2600(21)00218-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00218-6</ArticleId><ArticleId IdType="pmc">PMC8102044</ArticleId><ArticleId IdType="pubmed">33965003</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartleson J.M., Radenkovic D., Covarrubias A.J., Furman D., Winer D.A., Verdin E. SARS-CoV-2, COVID-19 and the aging immune system. Nat. Aging. 2021;1:769&#x2013;782. doi: 10.1038/s43587-021-00114-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43587-021-00114-7</ArticleId><ArticleId IdType="pmc">PMC8570568</ArticleId><ArticleId IdType="pubmed">34746804</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal A.D., VanElzakker M.B. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front. Microbiol. 2021;12:698169. doi: 10.3389/fmicb.2021.698169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D., Sun A., Ssentongo A.E., Ba D.M., Parsons N., Poudel G.R., Lekoubou A., Oh J.S., Ericson J.E., Ssentongo P., Chinchilli V.M. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Netw. Open. 2021;4:e2128568. doi: 10.1001/jamanetworkopen.2021.28568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell M.L., Catalfamo C.J., Farland L.V., Ernst K.C., Jacobs E.T., Klimentidis Y.C., Jehn M., Pogreba-Brown K. Post-acute sequelae of COVID-19 in a non-hospitalized cohort: results from the Arizona CoVHORT. PLoS One. 2021;16:e0254347. doi: 10.1371/journal.pone.0254347.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0254347</ArticleId><ArticleId IdType="pmc">PMC8336814</ArticleId><ArticleId IdType="pubmed">34347785</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., Pujol J.C., Klaser K., Antonelli M., Canas L.S., et al. Attributes and predictors of long COVID. Nat. Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S., Merad M. Pathological sequelae of long-haul COVID. Nat. Immunol. 2022;23:194&#x2013;202. doi: 10.1038/s41590-021-01104-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01104-y</ArticleId><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M., Blish C.A., Sallusto F., Iwasaki A. The immunology and immunopathology of COVID-19. Science. 2022;375:1122&#x2013;1127. doi: 10.1126/science.abm8108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm8108</ArticleId><ArticleId IdType="pubmed">35271343</ArticleId></ArticleIdList></Reference><Reference><Citation>Guler S.A., Ebner L., Aubry-Beigelman C., Bridevaux P.O., Brutsche M., Clarenbach C., Garzoni C., Geiser T.K., Lenoir A., Mancinetti M., et al. Pulmonary function and radiological features 4&#xa0;months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study. Eur. Respir. J. 2021;57:2003690. doi: 10.1183/13993003.03690-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03690-2020</ArticleId><ArticleId IdType="pmc">PMC8082329</ArticleId><ArticleId IdType="pubmed">33419891</ArticleId></ArticleIdList></Reference><Reference><Citation>Rai D.K., Sharma P., Kumar R. Post covid 19 pulmonary fibrosis. Is it real threat? Indian J. Tuberc. 2021;68:330&#x2013;333. doi: 10.1016/j.ijtb.2020.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijtb.2020.11.003</ArticleId><ArticleId IdType="pmc">PMC7654356</ArticleId><ArticleId IdType="pubmed">34099197</ArticleId></ArticleIdList></Reference><Reference><Citation>Liotti F.M., Menchinelli G., Marchetti S., Posteraro B., Landi F., Sanguinetti M., Cattani P. Assessment of SARS-CoV-2 RNA test results among patients who recovered from COVID-19 with prior negative results. JAMA Intern. Med. 2021;181:702. doi: 10.1001/jamainternmed.2020.7570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2020.7570</ArticleId><ArticleId IdType="pmc">PMC7662488</ArticleId><ArticleId IdType="pubmed">33180119</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J., Xiao J., Sun R., Tang X., Liang C., Lin H., Zeng L., Hu J., Yuan R., Zhou P., et al. Prolonged persistence of SARS-CoV-2 RNA in body fluids. Emerg. Infect. Dis. 2020;26:1834&#x2013;1838. doi: 10.3201/eid2608.201097.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2608.201097</ArticleId><ArticleId IdType="pmc">PMC7392422</ArticleId><ArticleId IdType="pubmed">32383638</ArticleId></ArticleIdList></Reference><Reference><Citation>Vibholm L.K., Nielsen S.S.F., Pahus M.H., Frattari G.S., Olesen R., Andersen R., Monrad I., Andersen A.H.F., Thomsen M.M., Konrad C.V., et al. SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses. eBioMedicine. 2021;64:103230. doi: 10.1016/j.ebiom.2021.103230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103230</ArticleId><ArticleId IdType="pmc">PMC7847186</ArticleId><ArticleId IdType="pubmed">33530000</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C., Wang Z., Lorenzi J.C.C., Muecksch F., Finkin S., Tokuyama M., Cho A., Jankovic M., Schaefer-Babajew D., Oliveira T.Y., et al. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021;591:639&#x2013;644. doi: 10.1038/s41586-021-03207-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03207-w</ArticleId><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Randall R.E., Griffin D.E. Within host RNA virus persistence: mechanisms and consequences. Curr. Opin. Virol. 2017;23:35&#x2013;42. doi: 10.1016/j.coviro.2017.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2017.03.001</ArticleId><ArticleId IdType="pmc">PMC5474179</ArticleId><ArticleId IdType="pubmed">28319790</ArticleId></ArticleIdList></Reference><Reference><Citation>Massey D., Berrent D., Akrami A., Assaf G., Davis H., Harris K., McCorkell L., Ring A.M., Schulz W.L., Wei H., et al. Change in symptoms and immune response in people with post-acute sequelae of SARS-Cov-2 infection (PASC) after SARS-Cov-2 vaccination. medRxiv. 2021 doi: 10.1101/2021.07.21.21260391. Preprint at.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.07.21.21260391</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodruff M.C., Ramonell R.P., Nguyen D.C., Cashman K.S., Saini A.S., Haddad N.S., Ley A.M., Kyu S., Howell J.C., Ozturk T., et al. Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19. Nat. Immunol. 2020;21:1506&#x2013;1516. doi: 10.1038/s41590-020-00814-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-00814-z</ArticleId><ArticleId IdType="pmc">PMC7739702</ArticleId><ArticleId IdType="pubmed">33028979</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C., Paschold L., Willscher E., Simnica D., W&#xf6;stemeier A., Muscate F., Wass M., Eisenmann S., Dutzmann J., Key&#xdf;er G., et al. Maturation trajectories and transcriptional landscape of plasmablasts and autoreactive B cells in COVID-19. iScience. 2021;24:103325. doi: 10.1016/j.isci.2021.103325.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2021.103325</ArticleId><ArticleId IdType="pmc">PMC8536484</ArticleId><ArticleId IdType="pubmed">34723157</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P., Gervais A., Le Voyer T., Rosain J., Philippot Q., Manry J., Michailidis E., Hoffmann H.H., Eto S., Garcia-Prat M., et al. Autoantibodies neutralizing type I IFNs are present in &#x223c;4% of uninfected individuals over 70 years old and account for &#x223c;20% of COVID-19 deaths. Sci. Immunol. 2021;6:eabl4340. doi: 10.1126/sciimmunol.abl4340.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abl4340</ArticleId><ArticleId IdType="pmc">PMC8521484</ArticleId><ArticleId IdType="pubmed">34413139</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang E.Y., Mao T., Klein J., Dai Y., Huck J.D., Jaycox J.R., Liu F., Zhou T., Israelow B., Wong P., et al. Diverse functional autoantibodies in patients with COVID-19. Nature. 2021;595:283&#x2013;288. doi: 10.1038/s41586-021-03631-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03631-y</ArticleId><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Borghi M.O., Beltagy A., Garrafa E., Curreli D., Cecchini G., Bodio C., Grossi C., Blengino S., Tincani A., Franceschini F., et al. Anti-phospholipid antibodies in COVID-19 are different from those detectable in the anti-phospholipid syndrome. Front. Immunol. 2020;11:584241. doi: 10.3389/fimmu.2020.584241.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.584241</ArticleId><ArticleId IdType="pmc">PMC7593765</ArticleId><ArticleId IdType="pubmed">33178218</ArticleId></ArticleIdList></Reference><Reference><Citation>El Hasbani G., Taher A.T., Jawad A., Uthman I. COVID-19, antiphospholipid antibodies, and Catastrophic antiphospholipid syndrome: a possible association? Clin. Med. Insights Arthritis Musculoskelet. Disord. 2020;13 doi: 10.1177/1179544120978667. 117954412097866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1179544120978667</ArticleId><ArticleId IdType="pmc">PMC7720319</ArticleId><ArticleId IdType="pubmed">33328777</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlachoyiannopoulos P.G., Magira E., Alexopoulos H., Jahaj E., Theophilopoulou K., Kotanidou A., Tzioufas A.G. Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID-19. Ann. Rheum. Dis. 2020;79:1661&#x2013;1663. doi: 10.1136/annrheumdis-2020-218009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-218009</ArticleId><ArticleId IdType="pubmed">32581086</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo Y., Estes S.K., Ali R.A., Gandhi A.A., Yalavarthi S., Shi H., Sule G., Gockman K., Madison J.A., Zuo M., et al. Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19. Sci. Transl. Med. 2020;12:eabd3876. doi: 10.1126/scitranslmed.abd3876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abd3876</ArticleId><ArticleId IdType="pmc">PMC7724273</ArticleId><ArticleId IdType="pubmed">33139519</ArticleId></ArticleIdList></Reference><Reference><Citation>Porritt R.A., Binek A., Paschold L., Rivas M.N., McArdle A., Yonker L.M., Alter G., Chandnani H.K., Lopez M., Fasano A., et al. The autoimmune signature of hyperinflammatory multisystem inflammatory syndrome in children. J.&#xa0;Clin. Invest. 2021;131:e151520. doi: 10.1172/JCI151520.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI151520</ArticleId><ArticleId IdType="pmc">PMC8516454</ArticleId><ArticleId IdType="pubmed">34437303</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Sawalha A.H., Lu Q. COVID-19 and autoimmune diseases. Curr. Opin. Rheumatol. 2021;33:155&#x2013;162. doi: 10.1097/BOR.0000000000000776.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0000000000000776</ArticleId><ArticleId IdType="pmc">PMC7880581</ArticleId><ArticleId IdType="pubmed">33332890</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed S., Zimba O., Gasparyan A.Y. COVID-19 and the clinical course of rheumatic manifestations. Clin. Rheumatol. 2021;40:2611&#x2013;2619. doi: 10.1007/s10067-021-05691-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-021-05691-x</ArticleId><ArticleId IdType="pmc">PMC7968918</ArticleId><ArticleId IdType="pubmed">33733315</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight J.S., Caricchio R., Casanova J.L., Combes A.J., Diamond B., Fox S.E., Hanauer D.A., James J.A., Kanthi Y., Ladd V., et al. The intersection of COVID-19 and autoimmunity. J.&#xa0;Clin. Invest. 2021;131:e154886. doi: 10.1172/jci154886.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci154886</ArticleId><ArticleId IdType="pmc">PMC8670833</ArticleId><ArticleId IdType="pubmed">34710063</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q., Bastard P., Karbuz A., Gervais A., Tayoun A.A., Aiuti A., Belot A., Bolze A., Gaudet A., Bondarenko A., et al. Human genetic and immunological determinants of critical COVID-19 pneumonia. Nature. 2022;603:587&#x2013;598. doi: 10.1038/s41586-022-04447-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04447-0</ArticleId><ArticleId IdType="pmc">PMC8957595</ArticleId><ArticleId IdType="pubmed">35090163</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreano E., Paciello I., Piccini G., Manganaro N., Pileri P., Hyseni I., Leonardi M., Pantano E., Abbiento V., Benincasa L., et al. Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants. Nature. 2021;600:530&#x2013;535. doi: 10.1038/s41586-021-04117-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04117-7</ArticleId><ArticleId IdType="pmc">PMC8674140</ArticleId><ArticleId IdType="pubmed">34670266</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson C. Vaccines may help clear up long-term covid-19 symptoms. New Sci. 2021;249:9. doi: 10.1016/S0262-4079(21)00396-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0262-4079(21)00396-1</ArticleId><ArticleId IdType="pmc">PMC7954517</ArticleId><ArticleId IdType="pubmed">33746325</ArticleId></ArticleIdList></Reference><Reference><Citation>Paschold L., Klee B., Gottschick C., Willscher E., Diexer S., Schulthei&#xdf; C., Simnica D., Sedding D., Girndt M., Gekle M., et al. Rapid hypermutation B cell trajectory recruits previously primed B cells upon third SARS-Cov-2 mRNA vaccination. Front. Immunol. 2022;13:876306. doi: 10.3389/fimmu.2022.876306.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.876306</ArticleId><ArticleId IdType="pmc">PMC9126551</ArticleId><ArticleId IdType="pubmed">35615365</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C., Paschold L., Simnica D., Mohme M., Willscher E., von Wenserski L., Scholz R., Wieters I., Dahlke C., Tolosa E., et al. Next-generation sequencing of T and B cell receptor repertoires from COVID-19 patients showed signatures associated with severity of disease. Immunity. 2020;53:442&#x2013;455.e4. doi: 10.1016/j.immuni.2020.06.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.06.024</ArticleId><ArticleId IdType="pmc">PMC7324317</ArticleId><ArticleId IdType="pubmed">32668194</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L.Y.C., Biggs C.M., Jamal S., Stukas S., Wellington C.L., Sekhon M.S. Soluble interleukin-6 receptor in the COVID-19 cytokine storm syndrome. Cell Rep. Med. 2021;2:100269. doi: 10.1016/j.xcrm.2021.100269.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2021.100269</ArticleId><ArticleId IdType="pmc">PMC8055165</ArticleId><ArticleId IdType="pubmed">33899032</ArticleId></ArticleIdList></Reference><Reference><Citation>Delorey T.M., Ziegler C.G.K., Heimberg G., Normand R., Yang Y., Segerstolpe &#xc5;., Abbondanza D., Fleming S.J., Subramanian A., Montoro D.T., et al. COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets. Nature. 2021;595:107&#x2013;113. doi: 10.1038/s41586-021-03570-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03570-8</ArticleId><ArticleId IdType="pmc">PMC8919505</ArticleId><ArticleId IdType="pubmed">33915569</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Kilian C., Turner J.E., Bosurgi L., Roedl K., Bartsch P., Gnirck A.C., Cortesi F., Schulthei&#xdf; C., Hellmig M., et al. Clonal expansion and activation of tissue-resident memory-like Th17 cells expressing GM-CSF in the lungs of severe COVID-19 patients. Sci. Immunol. 2021;6:eabf6692. doi: 10.1126/sciimmunol.abf6692.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abf6692</ArticleId><ArticleId IdType="pmc">PMC8128299</ArticleId><ArticleId IdType="pubmed">33622974</ArticleId></ArticleIdList></Reference><Reference><Citation>Wendisch D., Dietrich O., Mari T., von Stillfried S., Ibarra I.L., Mittermaier M., Mache C., Chua R.L., Knoll R., Timm S., et al. SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis. Cell. 2021;184:6243&#x2013;6261.e27. doi: 10.1016/j.cell.2021.11.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.11.033</ArticleId><ArticleId IdType="pmc">PMC8626230</ArticleId><ArticleId IdType="pubmed">34914922</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao M., Liu Y., Yuan J., Wen Y., Xu G., Zhao J., Cheng L., Li J., Wang X., Wang F., et al. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19. Nat. Med. 2020;26:842&#x2013;844. doi: 10.1038/s41591-020-0901-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0901-9</ArticleId><ArticleId IdType="pubmed">32398875</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson E., Reynolds G., Botting R.A., Calero-Nieto F.J., Morgan M.D., Tuong Z.K., Bach K., Sungnak W., Worlock K.B., Yoshida M., et al. Single-cell multi-omics analysis of the immune response in COVID-19. Nat. Med. 2021;27:904&#x2013;916. doi: 10.1038/s41591-021-01329-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01329-2</ArticleId><ArticleId IdType="pmc">PMC8121667</ArticleId><ArticleId IdType="pubmed">33879890</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulte-Schrepping J., Reusch N., Paclik D., Ba&#xdf;ler K., Schlickeiser S., Zhang B., Kr&#xe4;mer B., Krammer T., Brumhard S., Bonaguro L., et al. Severe COVID-19 is marked by a dysregulated myeloid cell compartment. Cell. 2020;182:1419&#x2013;1440.e23. doi: 10.1016/j.cell.2020.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.001</ArticleId><ArticleId IdType="pmc">PMC7405822</ArticleId><ArticleId IdType="pubmed">32810438</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Chen D., Yuan D., Lausted C., Choi J., Dai C.L., Voillet V., Duvvuri V.R., Scherler K., Troisch P., et al. Multi-Omics resolves a sharp disease-state shift between mild and moderate COVID-19. Cell. 2020;183:1479&#x2013;1495.e20. doi: 10.1016/j.cell.2020.10.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.10.037</ArticleId><ArticleId IdType="pmc">PMC7598382</ArticleId><ArticleId IdType="pubmed">33171100</ArticleId></ArticleIdList></Reference><Reference><Citation>Arango Duque G., Descoteaux A. Macrophage cytokines: involvement in immunity and infectious diseases. Front. Immunol. 2014;5:491. doi: 10.3389/fimmu.2014.00491.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2014.00491</ArticleId><ArticleId IdType="pmc">PMC4188125</ArticleId><ArticleId IdType="pubmed">25339958</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua R.L., Lukassen S., Trump S., Hennig B.P., Wendisch D., Pott F., Debnath O., Th&#xfc;rmann L., Kurth F., V&#xf6;lker M.T., et al. COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis. Nat. Biotechnol. 2020;38:970&#x2013;979. doi: 10.1038/s41587-020-0602-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-020-0602-4</ArticleId><ArticleId IdType="pubmed">32591762</ArticleId></ArticleIdList></Reference><Reference><Citation>Huynh L., Kusnadi A., Park S.H., Murata K., Park-Min K.H., Ivashkiv L.B. Opposing regulation of the late phase TNF response by mTORC1-IL-10 signaling and hypoxia in human macrophages. Sci. Rep. 2016;6:31959. doi: 10.1038/srep31959.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep31959</ArticleId><ArticleId IdType="pmc">PMC4997257</ArticleId><ArticleId IdType="pubmed">27558590</ArticleId></ArticleIdList></Reference><Reference><Citation>See&#xdf;le J., Waterboer T., Hippchen T., Simon J., Kirchner M., Lim A., M&#xfc;ller B., Merle U. Persistent symptoms in adult patients 1 Year after coronavirus disease 2019 (COVID-19): a prospective cohort study. Clin. Infect. Dis. 2021;74:1191&#x2013;1198. doi: 10.1093/cid/ciab611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab611</ArticleId><ArticleId IdType="pmc">PMC8394862</ArticleId><ArticleId IdType="pubmed">34223884</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans R.A., McAuley H., Harrison E.M., Shikotra A., Singapuri A., Sereno M., Elneima O., Docherty A.B., Lone N.I., Leavy O.C., et al. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study. Lancet Respir. Med. 2021;9:1275&#x2013;1287. doi: 10.1016/S2213-2600(21)00383-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00383-0</ArticleId><ArticleId IdType="pmc">PMC8497028</ArticleId><ArticleId IdType="pubmed">34627560</ArticleId></ArticleIdList></Reference><Reference><Citation>Moldofsky H., Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol. 2011;11:37. doi: 10.1186/1471-2377-11-37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-11-37</ArticleId><ArticleId IdType="pmc">PMC3071317</ArticleId><ArticleId IdType="pubmed">21435231</ArticleId></ArticleIdList></Reference><Reference><Citation>Mak I.W., Chu C.M., Pan P.C., Yiu M.G., Chan V.L. Long-term psychiatric morbidities among SARS survivors. Gen. Hosp. Psychiatry. 2009;31:318&#x2013;326. doi: 10.1016/j.genhosppsych.2009.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genhosppsych.2009.03.001</ArticleId><ArticleId IdType="pmc">PMC7112501</ArticleId><ArticleId IdType="pubmed">19555791</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed H., Patel K., Greenwood D.C., Halpin S., Lewthwaite P., Salawu A., Eyre L., Eyre L., O'Connor R., O'Connor R., et al. Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: a systematic review and meta-analysis. J.&#xa0;Rehabil. Med. 2020;52:jrm00063. doi: 10.2340/16501977-2694.</Citation><ArticleIdList><ArticleId IdType="doi">10.2340/16501977-2694</ArticleId><ArticleId IdType="pubmed">32449782</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganesh R., Grach S.L., Ghosh A.K., Bierle D.M., Salonen B.R., Collins N.M., Joshi A.Y., Boeder N.D., Jr., Anstine C.V., Mueller M.R., et al. The female-predominant persistent immune dysregulation of the post-COVID syndrome. Mayo Clin. Proc. 2022;97:454&#x2013;464. doi: 10.1016/j.mayocp.2021.11.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.11.033</ArticleId><ArticleId IdType="pmc">PMC8817110</ArticleId><ArticleId IdType="pubmed">35135695</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F., Tomasoni D., Falcinella C., Barbanotti D., Castoldi R., Mul&#xe8; G., Augello M., Mondatore D., Allegrini M., Cona A., et al. Female gender is associated with long COVID syndrome: a prospective cohort study. Clin. Microbiol. Infect. 2022;28:611.e9&#x2013;611.e16. doi: 10.1016/j.cmi.2021.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.11.002</ArticleId><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Bechmann N., Barthel A., Schedl A., Herzig S., Varga Z., Gebhard C., Mayr M., Hantel C., Beuschlein F., Wolfrum C., et al. Sexual dimorphism in COVID-19: potential clinical and public health implications. Lancet Diabetes Endocrinol. 2022;10:221&#x2013;230. doi: 10.1016/S2213-8587(21)00346-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(21)00346-6</ArticleId><ArticleId IdType="pmc">PMC8803381</ArticleId><ArticleId IdType="pubmed">35114136</ArticleId></ArticleIdList></Reference><Reference><Citation>Bunders M.J., Altfeld M. Implications of sex differences in immunity for SARS-CoV-2 pathogenesis and design of therapeutic Interventions. Immunity. 2020;53:487&#x2013;495. doi: 10.1016/j.immuni.2020.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.08.003</ArticleId><ArticleId IdType="pmc">PMC7430299</ArticleId><ArticleId IdType="pubmed">32853545</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein S.L., Flanagan K.L. Sex differences in immune responses. Nat. Rev. Immunol. 2016;16:626&#x2013;638. doi: 10.1038/nri.2016.90.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2016.90</ArticleId><ArticleId IdType="pubmed">27546235</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips S.P., Wei X., Kwong J.C., Gubbay J., Schwartz K.L., Majury A., Groome P.A. Duration of SARS-CoV-2 shedding: a population-based, Canadian study. PLoS One. 2021;16:e0252217. doi: 10.1371/journal.pone.0252217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0252217</ArticleId><ArticleId IdType="pmc">PMC8211234</ArticleId><ArticleId IdType="pubmed">34138906</ArticleId></ArticleIdList></Reference><Reference><Citation>Cevik M., Tate M., Lloyd O., Maraolo A.E., Schafers J., Ho A. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis. Lancet Microbe. 2021;2:e13&#x2013;e22. doi: 10.1016/S2666-5247(20)30172-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(20)30172-5</ArticleId><ArticleId IdType="pmc">PMC7837230</ArticleId><ArticleId IdType="pubmed">33521734</ArticleId></ArticleIdList></Reference><Reference><Citation>Wucherpfennig K.W. Mechanisms for the induction of autoimmunity by infectious agents. J.&#xa0;Clin. Invest. 2001;108:1097&#x2013;1104. doi: 10.1172/jci200114235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci200114235</ArticleId><ArticleId IdType="pmc">PMC209539</ArticleId><ArticleId IdType="pubmed">11602615</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakravarty E.F. Viral infection and reactivation in autoimmune disease. Arthritis Rheum. 2008;58:2949&#x2013;2957. doi: 10.1002/art.23883.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.23883</ArticleId><ArticleId IdType="pubmed">18821704</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Yuan D., Chen D.G., Ng R.H., Wang K., Choi J., Li S., Hong S., Zhang R., Xie J., et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881&#x2013;895.e20. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Simen B.B., Duman C.H., Simen A.A., Duman R.S. TNF&#x3b1; signaling in depression and anxiety: behavioral consequences of individual receptor targeting. Biol. Psychiatry. 2006;59:775&#x2013;785. doi: 10.1016/j.biopsych.2005.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2005.10.013</ArticleId><ArticleId IdType="pubmed">16458261</ArticleId></ArticleIdList></Reference><Reference><Citation>Berthold-Losleben M., Himmerich H. The TNFalpha system: functional aspects in depression, narcolepsy and psychopharmacology. Curr. Neuropharmacol. 2008;6:193&#x2013;202. doi: 10.2174/157015908785777238.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/157015908785777238</ArticleId><ArticleId IdType="pmc">PMC2687935</ArticleId><ArticleId IdType="pubmed">19506720</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung L., Cahill C.M. TNF-alpha and neuropathic pain--a review. J.&#xa0;Neuroinflammation. 2010;7:27. doi: 10.1186/1742-2094-7-27.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-7-27</ArticleId><ArticleId IdType="pmc">PMC2861665</ArticleId><ArticleId IdType="pubmed">20398373</ArticleId></ArticleIdList></Reference><Reference><Citation>Atzeni F., Nucera V., Masala I.F., Sarzi-Puttini P., Bonitta G. Il-6 Involvement in pain, fatigue and mood disorders in rheumatoid arthritis and the effects of Il-6 inhibitor sarilumab. Pharmacol. Res. 2019;149:104402. doi: 10.1016/j.phrs.2019.104402.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2019.104402</ArticleId><ArticleId IdType="pubmed">31536783</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y.Q., Liu Z., Liu Z.H., Chen S.P., Li M., Shahveranov A., Ye D.W., Tian Y.K. Interleukin-6: an emerging regulator of pathological pain. J.&#xa0;Neuroinflammation. 2016;13:141. doi: 10.1186/s12974-016-0607-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0607-6</ArticleId><ArticleId IdType="pmc">PMC4897919</ArticleId><ArticleId IdType="pubmed">27267059</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Donovan A., Hughes B.M., Slavich G.M., Lynch L., Cronin M.T., O'Farrelly C., Malone K.M. Clinical anxiety, cortisol and interleukin-6: evidence for specificity in emotion-biology relationships. Brain Behav. Immun. 2010;24:1074&#x2013;1077. doi: 10.1016/j.bbi.2010.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2010.03.003</ArticleId><ArticleId IdType="pmc">PMC4361085</ArticleId><ArticleId IdType="pubmed">20227485</ArticleId></ArticleIdList></Reference><Reference><Citation>Niraula A., Witcher K.G., Sheridan J.F., Godbout J.P. Interleukin-6 induced by social stress promotes a unique transcriptional signature in the monocytes that facilitate anxiety. Biol. Psychiatry. 2019;85:679&#x2013;689. doi: 10.1016/j.biopsych.2018.09.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2018.09.030</ArticleId><ArticleId IdType="pmc">PMC6440848</ArticleId><ArticleId IdType="pubmed">30447911</ArticleId></ArticleIdList></Reference><Reference><Citation>Goshen I., Kreisel T., Ben-Menachem-Zidon O., Licht T., Weidenfeld J., Ben-Hur T., Yirmiya R. Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression. Mol. Psychiatry. 2008;13:717&#x2013;728. doi: 10.1038/sj.mp.4002055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.mp.4002055</ArticleId><ArticleId IdType="pubmed">17700577</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren K., Torres R. Role of interleukin-1&#x3b2; during pain and inflammation. Brain Res. Rev. 2009;60:57&#x2013;64. doi: 10.1016/j.brainresrev.2008.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresrev.2008.12.020</ArticleId><ArticleId IdType="pmc">PMC3076185</ArticleId><ArticleId IdType="pubmed">19166877</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi S., Sacchetti L., Napolitano F., De Chiara V., Motta C., Studer V., Musella A., Barbieri F., Bari M., Bernardi G., et al. Interleukin-1 Causes anxiety by Interacting with the endocannabinoid system. J.&#xa0;Neurosci. 2012;32:13896&#x2013;13905. doi: 10.1523/JNEUROSCI.1515-12.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1515-12.2012</ArticleId><ArticleId IdType="pmc">PMC6704788</ArticleId><ArticleId IdType="pubmed">23035099</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi T., Ellingson M.K., Wong P., Israelow B., Lucas C., Klein J., Silva J., Mao T., Oh J.E., Tokuyama M., et al. Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature. 2020;588:315&#x2013;320. doi: 10.1038/s41586-020-2700-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2700-3</ArticleId><ArticleId IdType="pmc">PMC7725931</ArticleId><ArticleId IdType="pubmed">32846427</ArticleId></ArticleIdList></Reference><Reference><Citation>Koutsakos M., Rowntree L.C., Hensen L., Chua B.Y., van de Sandt C.E., Habel J.R., Zhang W., Jia X., Kedzierski L., Ashhurst T.M., et al. Integrated immune dynamics define correlates of COVID-19 severity and antibody responses. Cell Rep. Med. 2021;2:100208. doi: 10.1016/j.xcrm.2021.100208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2021.100208</ArticleId><ArticleId IdType="pmc">PMC7862905</ArticleId><ArticleId IdType="pubmed">33564749</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Valle D.M., Kim-Schulze S., Huang H.H., Beckmann N.D., Nirenberg S., Wang B., Lavin Y., Swartz T.H., Madduri D., Stock A., et al. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat. Med. 2020;26:1636&#x2013;1643. doi: 10.1038/s41591-020-1051-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-1051-9</ArticleId><ArticleId IdType="pmc">PMC7869028</ArticleId><ArticleId IdType="pubmed">32839624</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo M.S., Haag F., Nierhaus A., Jarczak D., Roedl K., Mayer C., Brehm T.T., van der Meirschen M., Hennigs A., Christopeit M., et al. Multi-dimensional and longitudinal systems profiling reveals predictive pattern of severe COVID-19. iScience. 2021;24:102752. doi: 10.1016/j.isci.2021.102752.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2021.102752</ArticleId><ArticleId IdType="pmc">PMC8213514</ArticleId><ArticleId IdType="pubmed">34179733</ArticleId></ArticleIdList></Reference><Reference><Citation>Investigators R.-C., Gordon A.C., Mouncey P.R., Al-Beidh F., Rowan K.M., Nichol A.D., Arabi Y.M., Annane D., Beane A., van Bentum-Puijk W., et al. Interleukin-6 receptor antagonists in critically ill patients with covid-19. N.&#xa0;Engl. J. Med. 2021;384:1491&#x2013;1502. doi: 10.1056/NEJMoa2100433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2100433</ArticleId><ArticleId IdType="pmc">PMC7953461</ArticleId><ArticleId IdType="pubmed">33631065</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosn L., Chaimani A., Evrenoglou T., Davidson M., Gra&#xf1;a C., Schmucker C., Bollig C., Henschke N., Sguassero Y., Nejstgaard C.H., et al. Interleukin-6 blocking agents for treating COVID-19: a living systematic review. Cochrane Database Syst. Rev. 2021;3:CD013881. doi: 10.1002/14651858.CD013881.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD013881</ArticleId><ArticleId IdType="pmc">PMC8406988</ArticleId><ArticleId IdType="pubmed">33734435</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose-John S. IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6. Int. J. Biol. Sci. 2012;8:1237&#x2013;1247. doi: 10.7150/ijbs.4989.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.4989</ArticleId><ArticleId IdType="pmc">PMC3491447</ArticleId><ArticleId IdType="pubmed">23136552</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C., Darley D.R., Wilson D.B., Howe A., Munier C.M.L., Patel S.K., Juno J.A., Burrell L.M., Kent S.J., Dore G.J., et al. Immunological dysfunction persists for 8&#xa0;months following initial mild-to-moderate SARS-CoV-2 infection. Nat. Immunol. 2022;23:210&#x2013;216. doi: 10.1038/s41590-021-01113-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Toraldo D.M., Satriano F., Rollo R., Verdastro G., Imbriani G., Rizzo E., Argentiero A., Falco A., Ambrosino P., Miani A., Piscitelli P. COVID-19 IgG/IgM patterns, early IL-6 elevation and long-term radiological sequelae in 75 patients hospitalized due to interstitial pneumonia followed up from 3 to 12&#xa0;months. PLoS One. 2022;17:e0262911. doi: 10.1371/journal.pone.0262911.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0262911</ArticleId><ArticleId IdType="pmc">PMC8863277</ArticleId><ArticleId IdType="pubmed">35192635</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson B.K., Francisco E.B., Yogendra R., Long E., Pise A., Rodrigues H., Hall E., Herrera M., Parikh P., Guevara-Coto J., et al. Persistence of SARS CoV-2 S1 protein in CD16+ monocytes in post-acute sequelae of COVID-19 (PASC) up to 15 Months post-infection. Front. Immunol. 2021;12:746021. doi: 10.3389/fimmu.2021.746021.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.746021</ArticleId><ArticleId IdType="pmc">PMC8784688</ArticleId><ArticleId IdType="pubmed">35082777</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Lu S., Tang A.F., Durstenfeld M.S., Ho H.E., Goldberg S.A., Forman C.A., Munter S.E., Hoh R., Tai V., et al. Markers of immune activation and inflammation in individuals with postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection. J.&#xa0;Infect. Dis. 2021;224:1839&#x2013;1848. doi: 10.1093/infdis/jiab490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab490</ArticleId><ArticleId IdType="pmc">PMC8643408</ArticleId><ArticleId IdType="pubmed">34677601</ArticleId></ArticleIdList></Reference><Reference><Citation>Theobald S.J., Simonis A., Georgomanolis T., Kreer C., Zehner M., Eisfeld H.S., Albert M.C., Chhen J., Motameny S., Erger F., et al. Long-lived macrophage reprogramming drives spike protein-mediated inflammasome activation in COVID-19. EMBO Mol. Med. 2021;13:e14150. doi: 10.15252/emmm.202114150.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.202114150</ArticleId><ArticleId IdType="pmc">PMC8350892</ArticleId><ArticleId IdType="pubmed">34133077</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohnacker S., Hartung F., Henkel F., Quaranta A., Kolmert J., Priller A., Ud-Dean M., Giglberger J., Kugler L.M., Pechtold L., et al. Mild COVID-19 imprints a long-term inflammatory eicosanoid- and chemokine memory in monocyte-derived macrophages. Mucosal Immunol. 2022;15:515&#x2013;524. doi: 10.1038/s41385-021-00482-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41385-021-00482-8</ArticleId><ArticleId IdType="pmc">PMC9038526</ArticleId><ArticleId IdType="pubmed">35288643</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson P.C., Liew D.F.L., Liew J.W., Monaco C., Richards D., Shivakumar S., Tanner H.L., Feldmann M. The potential for repurposing anti-TNF as a therapy for the treatment of COVID-19. Med. (N Y) 2020;1:90&#x2013;102. doi: 10.1016/j.medj.2020.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medj.2020.11.005</ArticleId><ArticleId IdType="pmc">PMC7713589</ArticleId><ArticleId IdType="pubmed">33294881</ArticleId></ArticleIdList></Reference><Reference><Citation>Investigators T.R.-C., Derde L.P.G. Effectiveness of tocilizumab, sarilumab, and anakinra for critically ill patients with COVID-19 the REMAP-CAP COVID-19 immune modulation therapy domain randomized clinical trial. medRxiv. 2021 doi: 10.1101/2021.06.18.21259133. Preprint at.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.06.18.21259133</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidson M., Menon S., Chaimani A., Evrenoglou T., Ghosn L., Gra&#xf1;a C., Henschke N., Cogo E., Villanueva G., Ferrand G., et al. Interleukin-1 blocking agents for treating COVID-19. Cochrane Database Syst. Rev. 2022;1:CD015308. doi: 10.1002/14651858.CD015308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD015308</ArticleId><ArticleId IdType="pmc">PMC8791232</ArticleId><ArticleId IdType="pubmed">35080773</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo P., Qiu L., Liu Y., Liu X.L., Zheng J.L., Xue H.Y., Liu W.H., Liu D., Li J. Metformin treatment was associated with decreased mortality in COVID-19 patients with diabetes in a retrospective analysis. Am. J. Trop. Med. Hyg. 2020;103:69&#x2013;72. doi: 10.4269/ajtmh.20-0375.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.20-0375</ArticleId><ArticleId IdType="pmc">PMC7356425</ArticleId><ArticleId IdType="pubmed">32446312</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Wei Q., Li W.X., McCowen K.C., Xiong W., Liu J., Jiang W., Marin T., Thomas R.L., He M., et al. Metformin use in diabetes prior to hospitalization: effects on mortality in covid-19. Endocr. Pract. 2020;26:1166&#x2013;1172. doi: 10.4158/EP-2020-0466.</Citation><ArticleIdList><ArticleId IdType="doi">10.4158/EP-2020-0466</ArticleId><ArticleId IdType="pmc">PMC7834011</ArticleId><ArticleId IdType="pubmed">33471718</ArticleId></ArticleIdList></Reference><Reference><Citation>Bramante C.T., Ingraham N.E., Murray T.A., Marmor S., Hovertsen S., Gronski J., McNeil C., Feng R., Guzman G., Abdelwahab N., et al. Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis. Lancet Healthy Longev. 2021;2:e34&#x2013;e41. doi: 10.1016/S2666-7568(20)30033-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-7568(20)30033-7</ArticleId><ArticleId IdType="pmc">PMC7832552</ArticleId><ArticleId IdType="pubmed">33521772</ArticleId></ArticleIdList></Reference><Reference><Citation>Xian H., Liu Y., Rundberg Nilsson A., Gatchalian R., Crother T.R., Tourtellotte W.G., Zhang Y., Aleman-Muench G.R., Lewis G., Chen W., et al. Metformin inhibition of mitochondrial ATP and DNA synthesis abrogates NLRP3 inflammasome activation and pulmonary inflammation. Immunity. 2021;54:1463&#x2013;1477.e11. doi: 10.1016/j.immuni.2021.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2021.05.004</ArticleId><ArticleId IdType="pmc">PMC8189765</ArticleId><ArticleId IdType="pubmed">34115964</ArticleId></ArticleIdList></Reference><Reference><Citation>Aziz N.A., Corman V.M., Echterhoff A.K.C., M&#xfc;ller M.A., Richter A., Schmandke A., Schmidt M.L., Schmidt T.H., de Vries F.M., Drosten C., Breteler M.M.B. Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies from a population-based study in Bonn, Germany. Nat. Commun. 2021;12:2117. doi: 10.1038/s41467-021-22351-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-22351-5</ArticleId><ArticleId IdType="pmc">PMC8035181</ArticleId><ArticleId IdType="pubmed">33837204</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F., for the Gemelli Against COVID-19 Post-Acute Care Study Group Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold D.T., Hamilton F.W., Milne A., Morley A.J., Viner J., Attwood M., Noel A., Gunning S., Hatrick J., Hamilton S., et al. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax. 2021;76:399&#x2013;401. doi: 10.1136/thoraxjnl-2020-216086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216086</ArticleId><ArticleId IdType="pmc">PMC7716340</ArticleId><ArticleId IdType="pubmed">33273026</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., Kang L., Guo L., Liu M., Zhou X., et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Korsunsky I., Millard N., Fan J., Slowikowski K., Zhang F., Wei K., Baglaenko Y., Brenner M., Loh P.R., Raychaudhuri S. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods. 2019;16:1289&#x2013;1296. doi: 10.1038/s41592-019-0619-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41592-019-0619-0</ArticleId><ArticleId IdType="pmc">PMC6884693</ArticleId><ArticleId IdType="pubmed">31740819</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>